dale
vivo
vitro
model
demyelin
diseas
xxiv
infecti
process
cyclosporin
treat
wistar
lewi
rat
inocul
jhm
viru
microbi
pathogenesi
present
studi
investig
age
relat
effect
inoculum
size
cellular
immun
cn
diseas
caus
jhm
viru
jhmv
wistar
lewi
wl
rat
onset
resist
normal
becom
evid
day
inocul
made
pfu
less
resist
could
abrog
day
old
anim
increas
dose
twofold
rare
except
day
old
rat
increas
pfu
fail
surmount
resist
howev
treatment
immunosuppress
drug
cyclosporin
csa
abolish
resist
wherebi
rat
challeng
day
age
suscept
jhmv
histopatholog
evid
diseas
symptom
csa
treat
group
resembl
close
observ
previou
studi
athym
nude
rat
microscop
examin
cn
untreat
infect
rat
reveal
extens
inflammatori
respons
character
perivascular
cuf
mononuclear
infiltr
neuropil
parallel
csa
treat
group
show
inflammatori
respons
type
cn
either
minim
absent
present
evid
conclud
jhmv
infect
involv
neuron
oligodendrocyt
element
kept
check
cellular
immun
system
cellular
immun
suppress
absent
diseas
process
alter
one
white
matter
demyelin
predomin
anoth
form
diseas
neuron
involv
promin
inocul
inbr
rat
defin
quantiti
coronaviru
jhm
jhmv
elicit
differ
type
neurolog
diseas
depend
age
viru
inocul
intracerebr
c
infect
initi
first
day
life
result
rapidli
fatal
acut
encephalomyel
extens
destruct
grey
matter
occur
older
preweanl
rat
challeng
delay
chronic
diseas
frequent
develop
character
progress
paralysi
presenc
extens
lesion
white
matter
wistar
lewi
wl
well
sever
outbr
rat
strain
test
us
anim
becom
resist
jhmv
day
life
wherea
wistar
furth
wf
rat
remain
suscept
viru
wean
day
birth
hypothes
agerel
differ
wl
wf
strain
may
connect
dissimilar
growth
rate
matur
cn
idea
support
vitro
studi
demonstr
relationship
exist
oligodendrocyt
differenti
matur
resist
infect
jhmv
anoth
factor
control
neurolog
diseas
induc
rat
jhmv
cellular
immun
rat
either
immunosuppress
cyclosporin
csa
genet
athym
remain
suscept
infect
beyond
normal
age
resist
even
well
past
wean
clarifi
role
jhmv
cellular
immun
system
studi
examin
influenc
inoculum
size
age
csa
immunosuppress
diseas
process
relationship
inoculum
size
agerel
suscept
jhmv
sever
previou
articl
report
wl
rat
fail
develop
diseas
inocul
c
pfu
jhmv
day
birth
find
confirm
present
studi
tabl
influenc
age
size
inoculum
immunosuppress
cyclosporin
neurolog
diseas
wistar
lewi
rat
group
inocul
pfu
jhmv
group
x
pfu
group
pfu
group
rat
treat
csa
group
b
receiv
daili
csa
inject
commenc
day
day
treatment
suspend
resum
day
postpartum
group
receiv
daili
csa
inject
commenc
day
suppress
day
resum
day
postpartum
group
inject
daili
csa
commenc
day
day
post
jhmv
inocul
group
receiv
daili
csa
inject
commenc
day
age
group
receiv
daili
csa
inject
commenc
day
suspend
day
resum
day
postpartum
group
receiv
csa
daili
commenc
day
day
post
jhmv
inocul
group
inject
daili
csa
start
day
day
postpartum
group
csa
treatment
resum
examin
whether
resist
prior
wean
overcom
increas
viru
dose
challeng
one
group
day
old
anim
group
tabl
pfu
anoth
day
age
group
pfu
third
day
old
group
pfu
evid
data
tabl
one
eight
rat
group
develop
neurolog
symptom
wherea
five
seven
rat
group
receiv
five
time
viru
age
becam
diseas
among
anim
challeng
pfu
jhmv
day
old
one
develop
late
onset
progress
paralyt
diseas
type
describ
us
previous
appar
data
day
age
inocul
c
five
time
viru
standard
dose
pfu
may
suffici
overcom
resist
howev
day
time
greater
jhmv
inocula
occasion
surmount
resist
wl
rat
effect
cyclosporin
agerel
resist
neurolog
diseas
caus
jhmv
investig
athym
rnurnu
rat
show
c
inocul
jhmv
even
delay
day
life
frequent
result
neurolog
diseas
includ
paralysi
data
present
studi
reveal
csa
treatment
abrog
normal
agerel
resist
jhmv
rat
challeng
tenth
day
age
tabl
howev
effect
drug
administ
day
ahead
viru
inocul
continu
thereaft
rat
group
tabl
initi
csa
treatment
delay
day
inject
viru
group
day
group
treatment
around
time
inocul
termin
resum
group
diseas
develop
presum
resist
maintain
evid
csa
promot
mainten
replic
jhmv
cn
tabl
relationship
immunosuppress
csa
time
elaps
viru
activ
cn
wistar
lewi
rat
rat
inocul
c
day
age
pfu
day
postpartum
daili
inject
csa
commenc
termin
day
resum
day
continu
time
sacrific
singl
untreat
anim
develop
chronic
paralyt
diseas
symptom
sorensen
et
al
control
pfug
brain
symptom
treat
csa
pfug
brain
cyclosporin
treatment
activ
jhmv
cn
associ
csa
treatment
manifest
diseas
symptom
postweanl
wl
rat
led
us
carri
systemat
test
presenc
infecti
viru
shown
tabl
test
rat
manifest
diseas
symptom
contain
high
titer
jhmv
brain
one
case
quantiti
exceed
pfug
agerel
control
untreat
csa
viru
detect
singl
rat
group
test
anim
spontan
activ
occur
titer
pfug
brain
log
less
pfu
found
agerel
csa
treat
litterm
tabl
effici
clear
eclips
jhmv
less
one
day
c
inocul
evid
assay
carri
brain
csatreat
control
rat
tabl
unambigu
result
show
input
viru
contribut
jhmv
titer
detect
day
postinocul
beyond
combin
data
tabl
indic
effect
csa
place
around
time
viru
inocul
continu
thereaft
group
tabl
must
present
within
day
initi
treatment
group
tabl
reactiv
latent
type
jhmv
infect
establish
maintain
effect
jhmv
infect
cyclosporin
histopatholog
cn
wl
rat
older
ten
day
inocul
c
pfu
jhmv
neurolog
diseas
symptom
rare
manifest
present
studi
examin
histolog
section
prepar
variou
cn
region
rat
inocul
day
among
group
anim
tabl
evid
tissu
necrosi
howev
promin
inflammatori
respons
clearli
present
fig
c
similar
inflammatori
respons
found
cn
csa
untreat
rat
group
infect
day
group
rat
infect
day
illustr
fig
b
contrast
multipl
lesion
present
cn
csatreat
litter
mate
group
anim
sign
inflamm
absent
much
less
promin
fig
c
presenc
lesion
could
correl
diseas
symptom
well
high
viru
titer
data
tabl
diseas
process
associ
csa
manifest
rapidli
initi
lethargi
ataxia
first
day
hind
leg
paresi
second
day
rat
unless
sacrif
time
invari
die
within
h
appear
earli
symptom
rapidli
develop
diseas
contrast
prolong
chronic
progress
paralysi
associ
jhmv
infect
untreat
anim
tissu
necrosi
group
princip
grey
matter
tissu
diencephalon
mesencephalon
fig
spinal
cord
rhombencephalon
includ
cerebellum
grey
white
matter
necrot
foci
found
frequent
rare
observ
featur
histopatholog
among
csa
treat
rat
group
massiv
mononuclear
cell
infiltr
mening
one
exampl
diencephalon
region
close
cerebellum
illustr
fig
b
determin
whether
inflammatori
respons
cn
necrot
lesion
observ
jhmv
infect
wl
rat
similar
found
experiment
allerg
encephalomyel
eae
autoimmun
diseas
induc
neural
antigen
immun
week
old
anim
homogen
guinea
pig
spinal
cord
gpsc
accord
experiment
protocol
feurer
et
al
nine
wl
rat
receiv
gpsc
develop
chronicrelaps
eae
exactli
describ
feurer
et
al
within
day
inject
antigen
hind
foot
pad
among
initi
symptom
loss
tail
tonic
gradual
becam
sever
progress
hind
leg
paresi
within
next
week
anim
recov
suffer
relaps
within
next
two
week
histolog
section
spinal
cord
cerebellum
anim
sacrif
display
hind
leg
paresi
reveal
extens
perivascular
cuf
spinal
cord
fig
consider
infiltr
cerebellar
tissu
comparison
six
agematch
wf
rat
manifest
low
grade
inflammatori
process
jhmv
infect
inject
gpsc
fail
develop
symptom
eae
howev
within
four
day
inject
edema
inflamm
observ
hind
feet
among
wf
group
symptom
disappear
perman
subsequ
three
day
section
cn
survey
histopatholog
fail
reveal
tissu
destruct
evid
inflamm
compar
fig
b
observ
conclud
wf
rat
suscept
type
eae
provok
neural
antigen
wl
rat
aspect
neurolog
diseas
rat
induc
jhmv
consid
present
studi
resist
c
infect
postnat
develop
b
role
cellular
immun
possibl
relationship
host
genet
endow
wl
rat
resist
jhmv
limit
inoculum
pfu
set
day
age
surmount
increas
quantiti
viru
consequ
even
day
old
rat
challeng
occasion
succumb
late
onset
chronic
paralyt
diseas
demyelin
white
matter
predomin
find
impli
wean
cn
myelin
complet
rat
lower
probabl
jhmv
infect
suscept
oligodendrocyt
target
viru
specif
tropism
treatment
wl
rat
csa
concentr
known
suppress
cellular
immun
effect
abrog
agerel
resist
jhmv
even
day
old
anim
howev
ensu
diseas
process
differ
untreat
control
virtual
ident
one
observ
post
weanl
athym
rnurnu
rat
studi
us
previous
among
nude
csa
treat
group
brief
interv
two
three
day
appear
symptom
onset
paralysi
manifest
convuls
death
cn
histopatholog
immunodefici
rat
reveal
neuron
infect
predomin
promin
hippocamp
rhombocephal
area
multipl
lesion
encount
histopatholog
may
explain
cours
diseas
rapid
occurr
necrot
lesion
albeit
small
white
matter
indic
oligodendrocyt
perhap
nonneuron
cell
type
may
also
affect
anoth
strike
rare
encount
similar
csatreat
nude
rat
accumul
mening
massiv
quantiti
mononuclear
cell
shown
sorensen
et
al
fig
b
differ
form
cn
diseas
develop
normal
versu
immunodefici
rat
undoubtedli
connect
cellular
rather
humor
immun
intrathec
product
antijhmv
immunoglobulin
appear
influenc
progress
chronic
diseas
euthym
rat
spread
infect
neuron
may
occur
readili
csa
treat
rat
reservoir
jhmv
maintain
specif
site
grey
matter
brain
reveal
situ
probe
presum
cellular
immun
lack
spread
viru
repositori
site
interrupt
infect
becom
dissemin
rather
limit
involv
white
matter
diseas
older
csa
treat
rat
perhap
due
pauciti
suscept
oligodendrocyt
target
sinc
cell
type
becom
refractori
infect
jhmv
agerel
differenti
occur
studi
abl
demonstr
correl
replic
jhmv
cn
manifest
diseas
among
rat
infect
day
age
one
control
anim
develop
lateonset
paralysi
virtual
treat
csa
contain
viru
brain
tabl
undoubtedli
progeni
viru
infecti
inoculum
rapidli
eclips
undetect
level
howev
infecti
potenti
inoculum
maintain
brain
viru
becom
subsequ
trigger
product
replic
occur
often
immunosuppress
rat
rather
infrequ
untreat
anim
studi
normal
wf
rat
evid
latenc
jhmv
occasion
prolong
wherebi
viru
express
cn
detect
beyond
day
c
inocul
initi
period
day
around
time
inocul
must
critic
establish
latent
viru
reservoir
immunosuppress
csa
effect
decis
interv
furthermor
perpetu
infect
csa
treatment
must
maintain
resum
within
day
suggest
preweanl
wl
rat
cellular
immun
effect
keep
check
perhap
entir
elimin
infect
evid
other
jh
mv
induc
prolifer
cell
recogn
myelin
antigen
specif
mbp
cell
use
adopt
transfer
eae
provid
prepar
cn
sampl
histopatholog
remov
cn
control
rat
manifest
diseas
symptom
tissu
divid
sagit
equal
halv
one
half
homogen
employ
estim
viru
titer
assay
plaqu
form
unit
pfu
half
fix
buffer
formaldehyd
neutral
ph
dehydr
embed
section
stain
hematoxylin
eosin
describ
previous
viru
inocul
assay
jhmv
propag
cell
quantit
plaqu
assay
previous
describ
pfu
inoculum
inject
c
vari
depend
experiment
group
involv
describ
legend
tabl
rat
group
receiv
pfu
day
age
respect
group
inject
day
age
x
pfu
rat
group
receiv
x
pfu
day
age
titer
jhmv
cn
obtain
plaqu
assay
cell
monolay
mean
dilut
seri
brain
homogen
sorensen
et
al
fate
infecti
inoculum
brain
determin
day
postinocul
immunosuppress
cyclosporin
cyclosporin
csa
obtain
sandimmun
sandoz
canada
inc
inject
intraperiton
p
deliv
mgkgday
accord
schedul
shown
tabl
chronicrelaps
experiment
allerg
encephalomyel
creae
induc
chronic
relaps
type
eae
describ
feurer
et
al
spinal
cord
guinea
pig
gpsc
isol
anim
homogen
prepar
emuls
inocul
gpsc
antigen
emulsifi
complet
freund
adjuv
bcg
cell
wall
ad
inject
hind
foot
pad
week
old
wl
wf
rat
assess
eae
accord
criteria
feurer
et
al
grate
andrea
hanington
mainten
anim
coloni
ole
sorensen
suggest
discuss
